These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 37314244

  • 1. Prehospital Tranexamic Acid for Severe Trauma.
    PATCH-Trauma Investigators and the ANZICS Clinical Trials Group, Gruen RL, Mitra B, Bernard SA, McArthur CJ, Burns B, Gantner DC, Maegele M, Cameron PA, Dicker B, Forbes AB, Hurford S, Martin CA, Mazur SM, Medcalf RL, Murray LJ, Myles PS, Ng SJ, Pitt V, Rashford S, Reade MC, Swain AH, Trapani T, Young PJ.
    N Engl J Med; 2023 Jul 13; 389(2):127-136. PubMed ID: 37314244
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
    Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA.
    JAMA; 2020 Sep 08; 324(10):961-974. PubMed ID: 32897344
    [Abstract] [Full Text] [Related]

  • 4. Protocol for a multicentre prehospital randomised controlled trial investigating tranexamic acid in severe trauma: the PATCH-Trauma trial.
    Mitra B, Bernard S, Gantner D, Burns B, Reade MC, Murray L, Trapani T, Pitt V, McArthur C, Forbes A, Maegele M, Gruen RL, PATCH-Trauma study investigators, PATCH-Trauma Study investigators.
    BMJ Open; 2021 Mar 15; 11(3):e046522. PubMed ID: 33722875
    [Abstract] [Full Text] [Related]

  • 5. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Ciccone A, Collins R, Dineen RA, Duley L, Egea-Guerrero JJ, England TJ, Karlinski M, Krishnan K, Laska AC, Law ZK, Ovesen C, Ozturk S, Pocock SJ, Roberts I, Robinson TG, Roffe C, Peters N, Scutt P, Thanabalan J, Werring D, Whynes D, Woodhouse L, Bath PM.
    Health Technol Assess; 2019 Jul 15; 23(35):1-48. PubMed ID: 31322116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial.
    Nishijima DK, Kuppermann N, Roberts I, VanBuren JM, Tancredi DJ.
    Ann Emerg Med; 2019 Jul 15; 74(1):79-87. PubMed ID: 30642657
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: A subgroup analysis from the prehospital TXA for TBI trial.
    Rowell S, Meier EN, Hoyos Gomez T, Fleming M, Jui J, Morrison L, Bulger E, Sopko G, Weisfeldt M, Christenson J, Klotz P, McMullan J, Callum J, Sheehan K, Tibbs B, Aufderheide T, Cotton B, Gandhi R, Idris A, Frascone RJ, Ferrara M, Richmond N, Kannas D, Schlamp R, Robinson B, Dries D, Tallon J, Hendrickson A, Gamber M, Garrett J, Simonson R, McKinley WI, Schreiber M.
    J Trauma Acute Care Surg; 2024 Oct 01; 97(4):572-580. PubMed ID: 38685481
    [Abstract] [Full Text] [Related]

  • 13. Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury.
    Bossers SM, Loer SA, Bloemers FW, Den Hartog D, Van Lieshout EMM, Hoogerwerf N, van der Naalt J, Absalom AR, Peerdeman SM, Schwarte LA, Boer C, Schober P, BRAIN-PROTECT collaborators.
    JAMA Neurol; 2021 Mar 01; 78(3):338-345. PubMed ID: 33284310
    [Abstract] [Full Text] [Related]

  • 14. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
    CRASH-2 collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. crash@lshtm.ac.uk, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T.
    Lancet; 2011 Mar 26; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
    [Abstract] [Full Text] [Related]

  • 15. Tranexamic acid for patients with nasal haemorrhage (epistaxis).
    Joseph J, Martinez-Devesa P, Bellorini J, Burton MJ.
    Cochrane Database Syst Rev; 2018 Dec 31; 12(12):CD004328. PubMed ID: 30596479
    [Abstract] [Full Text] [Related]

  • 16. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
    Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM, STOP-MSU Trial Investigators.
    Lancet Neurol; 2024 Jun 31; 23(6):577-587. PubMed ID: 38648814
    [Abstract] [Full Text] [Related]

  • 17. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    CRASH-2 trial collaboratorsClinical Trials Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S.
    Lancet; 2010 Jul 03; 376(9734):23-32. PubMed ID: 20554319
    [Abstract] [Full Text] [Related]

  • 18. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, Cooper DJ, Marasco S, McNeil J, Bussières JS, McGuinness S, Byrne K, Chan MT, Landoni G, Wallace S, ATACAS Investigators of the ANZCA Clinical Trials Network.
    N Engl J Med; 2017 Jan 12; 376(2):136-148. PubMed ID: 27774838
    [Abstract] [Full Text] [Related]

  • 19. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.
    Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, Manno D, Shakur H, Stanworth S, Veitch A.
    Trials; 2014 Nov 19; 15():450. PubMed ID: 25409738
    [Abstract] [Full Text] [Related]

  • 20. Tranexamic acid for upper gastrointestinal bleeding.
    Bennett C, Klingenberg SL, Langholz E, Gluud LL.
    Cochrane Database Syst Rev; 2014 Nov 21; 2014(11):CD006640. PubMed ID: 25414987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.